| Patricia Mae Zabala Luna, PHARMD | |
|
6122 W Bennington Dr, Fresno, CA 93722-2670 | |
| (559) 916-0985 | |
| Not Available |
| Full Name | Patricia Mae Zabala Luna |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 6122 W Bennington Dr, Fresno, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205520368 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 87923 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Patricia Mae Zabala Luna, PHARMD 6122 W Bennington Dr, Fresno, CA 93722-2670 Ph: (559) 916-0985 | Patricia Mae Zabala Luna, PHARMD 6122 W Bennington Dr, Fresno, CA 93722-2670 Ph: (559) 916-0985 |
News Archive
Medicare on average provides less generous benefits to seniors than they would receive under a typical large-employer health plan or the most popular plan available to federal employees – even with the program's new drug benefit, according to a new Kaiser Family Foundation analysis.
Cell Therapeutics, Inc. (CTI) has announced that the U.S. Food and Drug Administration (FDA) has accepted for filing and review, and has granted priority review status for, the supplemental Biologics License Application (sBLA) for use of Zevalin ([90Y]-ibritumomab tiuxetan) as consolidation therapy for patients with follicular B-cell non-Hodgkin's lymphoma who achieve a response to first-line therapy. Priority review is granted by the FDA for a treatment that addresses a significant unmet medical need.
A network of children's hospitals, data partners, and specialty networks led by The Children's Hospital of Philadelphia was recently approved for an award from the Patient-Centered Outcomes Research Institute (PCORI) to develop and expand its work as part of PCORnet: the National Patient-Centered National Clinical Research Network.
Organized by Pharma IQ, a division of IQPC, the Anti-Infectives Summit will be held January 25-27, 2010 in Philadelphia, PA (www.anti-infectivesummit.com). This forum explores recent advances within anti-infective drug discovery and development, and is geared towards Chief Scientific Officers and Scientists working in microbiology, immunology, infectious diseases, medicinal chemistry and drug development.
Disease-free survival for invasive ductal breast cancer (IDC) patients may be easier to predict with the help of F-18-fludeoxyglucose positron emission tomography (PET)/computed tomography (CT) scans, according to research published in the September issue of The Journal of Nuclear Medicine. New data show that high maximum standard uptake value (SUVmax) of F-18-FDG in the lymph nodes prior to treatment could be an independent indicator of disease recurrence.
› Verified 1 days ago
Dr. Alis Filipioglu-fago, PHARM. D., RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7535 N Palm Ave Ste 101, Fresno, CA 93711 Phone: 559-432-9800 Fax: 559-432-2349 | |
Dr. Lynice Fou, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7300 N Fresno St, Fresno, CA 93720 Phone: 559-448-3305 Fax: 559-448-3350 | |
Yuri Cho, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 740 W Alluvial Ave, Suite 101, Fresno, CA 93711 Phone: 800-797-3543 | |
Johnny Quoc Nguyen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7015 N West Ave, Fresno, CA 93711 Phone: 559-440-1404 Fax: 559-440-1407 | |
Penang Pham, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6074 N 1st St, Fresno, CA 93710 Phone: 559-431-5231 | |
Dr. Jagdip Jaspal, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 504 East Herndon Ave Suite 101, Fresno, CA 93720 Phone: 559-438-9888 | |
Dr. James Michael Winton, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4233 E Tulare St, Fresno, CA 93702 Phone: 559-255-3071 |